| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740416 | Journal of Infection | 2018 | 17 Pages |
Abstract
Overall, low quality data suggest that IV/INHCC did not lower mortality in patients with MDR Gram negative infections unless low IV colistin dose was administered.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Konstantinos Z. Vardakas, Andreas D. Mavroudis, Maria Georgiou, Matthew E. Falagas,